It is well stablished that IL-10 released by Treg improves endothelial dysfunction through inhibition of vascular NADPH oxidase activity improving vascular oxidative stress [50], which contributes to reduce blood pressure in IMQ-treated mice. The gene discussed is FMO5; the disease is endothelial dysfunction.